In 1971 Dr. Judah Folkman announced to the world that angiogenesis would be the Achilles heel of cancer-what's happened in the last 35 years? Dr. Walter M. Stadler, professor of medicine, director of Genitourinary Program, and associate dean of Clinical Research at the University of Chicago Medical Center joins host Dr. Bruce Bloom to fast forward from that early discovery to the current cutting edge uses for Avastin and other anti-angiogenics in cancer, including successes and shortcomings of this class of drugs in treating both solid tumors and blood cancers .